Reply to Alaedini and Wormser
Clin Infect Dis
.
2023 Apr 3;76(7):1342-1343.
doi: 10.1093/cid/ciac896.
Authors
Zoe Swank
1
2
3
,
Yasmeen Senussi
1
2
3
,
Zachary Manickas-Hill
4
,
Xu G Yu
1
4
5
,
Jonathan Z Li
1
5
,
Galit Alter
4
6
,
David R Walt
1
2
3
Affiliations
1
Harvard Medical School, Boston, Massachusetts, USA.
2
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
3
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
4
Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
5
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
6
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
PMID:
36385394
DOI:
10.1093/cid/ciac896
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
Grants and funding
Sanofi
AbbVie
Gilead
Pfizer
Amos